Home › Trials › NCT06834646
Clinical trial Recruiting at 1 site Observational Ages 18 and up

30-day outcomes for cancer patients treated in specialist versus non-specialist emergency departments

Official title: Comparison of 30-day Morbidity and Mortality in Cancer Patients Based on Emergency Department Location: Referring Oncology Hospital vs Other Hospitals.

Run by Assistance Publique - Hôpitaux de Paris · NCT06834646 · Data updated 2026-11-12

This study will see if adults with active cancer or cancer remission within the past year who go to a specialist cancer emergency department have different 30-day death and complication rates compared with those who go to non-specialist emergency departments.

More Breast Cancer trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2000 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedApril 12, 2025
Main results expectedSeptember 2026
Study endsSeptember 2026
Registry record updatedJanuary 20, 2026
Trial IDNCT06834646 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with active cancer or cancer in remission for less than one year who present to an emergency department and consent to record use are the intended participants.

Probably not a fit

Patients under 18, those whose cancer has been in remission for more than one year, or individuals who withhold consent are unlikely to benefit from enrollment in this observational project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational cohort comparison of adults with active cancer or cancer in remission for less than one year who present to an emergency department. Investigators will record the ED location (specialist cancer ED versus non-specialist ED), access to oncology records, presenting severity, treatments given, and 30-day outcomes including complications and mortality. Outcomes will be compared between groups using statistical adjustment for baseline illness severity and treatment factors. No interventional procedures are performed as part of the protocol.

Why it matters

Potential benefit: If specialist ED care is linked to better 30-day outcomes, the findings could promote referral pathways or shared-care processes that reduce short-term complications and deaths for cancer patients.

How similar studies have gone: Prior work has suggested that cancer-center expertise can improve care quality and prognosis, but direct comparisons of 30-day morbidity and mortality by ED location are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

Patients aged 18 or over admitted to an emergency department with cancer that has been active or in remission for less than a year.

Exclusion Criteria:

\- Opposition to participate in the study

Where it's running

  • Hôpital Pitié Salpêtrière Emergency department
    Paris, France     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Cancer Remission 4Assistance Publique - Hôpitaux de Paris 536
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.